This company is no longer active
Resumen de acción PCBK
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Sesen Bio, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$10.25 |
| 52 Week High | US$18.19 |
| 52 Week Low | US$6.88 |
| Beta | 0.83 |
| 1 Month Change | -4.21% |
| 3 Month Change | 3.08% |
| 1 Year Change | -8.66% |
| 3 Year Change | -22.36% |
| 5 Year Change | -41.71% |
| Change since IPO | -31.59% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| PCBK | DE Biotechs | Mercado DE | |
|---|---|---|---|
| 7D | -4.6% | 2.2% | -1.0% |
| 1Y | -8.7% | -22.2% | 2.2% |
Rentabilidad vs. Industria: PCBK underperformed the German Biotechs industry which returned 10.9% over the past year.
Rentabilidad vs. Mercado: PCBK underperformed the German Market which returned 2.2% over the past year.
Volatilidad de los precios
| PCBK volatility | |
|---|---|
| PCBK Average Weekly Movement | 18.9% |
| Biotechs Industry Average Movement | 5.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Precio estable de las acciones: PCBK's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: PCBK's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of German stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2008 | 17 | Thomas Cannell | sesenbio.com |
Resumen de fundamentos de Sesen Bio, Inc.
| Estadísticas fundamentales de PCBK | |
|---|---|
| Capitalización bursátil | €2.42b |
| Beneficios(TTM) | -€18.84m |
| Ingresos (TTM) | €37.90m |
64.0x
Ratio precio-ventas (PS)-128.7x
Ratio precio-beneficio (PE)¿Está PCBK sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de PCBK | |
|---|---|
| Ingresos | US$40.00m |
| Coste de los ingresos | US$1.99m |
| Beneficio bruto | US$38.02m |
| Otros gastos | US$57.90m |
| Beneficios | -US$19.88m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.098 |
| Margen bruto | 95.04% |
| Margen de beneficio neto | -49.71% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado PCBK a largo plazo?
Ver rendimiento histórico y comparativa